Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,705.00
Bid: 1,701.00
Ask: 1,701.50
Change: 32.00 (1.91%)
Spread: 0.50 (0.029%)
Open: 1,685.50
High: 1,718.50
Low: 1,673.00
Prev. Close: 1,705.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATINGS SUMMARY: Deutsche Bank Starts Taylor Wimpey At Buy

Tue, 03rd Sep 2019 09:40

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

----------

FTSE 100

----------

DEUTSCHE BANK INITIATES TAYLOR WIMPEY WITH 'BUY' - TARGET 187 PENCE

----------

DEUTSCHE BANK RESUMES BARRATT DEVELOPMENTS WITH 'HOLD' - TARGET 648 PENCE

----------

DEUTSCHE BANK RESUMES BERKELEY GROUP WITH 'SELL' - TARGET 3428 PENCE

----------

DEUTSCHE BANK RESUMES PERSIMMON WITH 'BUY' - TARGET 2386 PENCE

----------

BARCLAYS RAISES RSA INSURANCE PRICE TARGET TO 603 (600) PENCE - 'OVERWEIGHT'

----------

BARCLAYS RAISES PRUDENTIAL PRICE TARGET TO 2088 (2069) PENCE - 'OVERWEIGHT'

----------

BARCLAYS CUTS PHOENIX GROUP PRICE TARGET TO 657 (664) PENCE - 'EQUAL WEIGHT'

----------

BARCLAYS RAISES LEGAL & GENERAL PRICE TARGET TO 331 (320) PENCE - 'OVERWEIGHT'

----------

BARCLAYS RAISES HISCOX PRICE TARGET TO 1556 (1514) PENCE - 'UNDERWEIGHT'

----------

BARCLAYS CUTS DIRECT LINE PRICE TARGET TO 347 (354) PENCE - 'EQUAL WEIGHT'

----------

BARCLAYS RAISES AVIVA PRICE TARGET TO 551 (550) PENCE - 'OVERWEIGHT'

----------

BARCLAYS CUTS ADMIRAL GROUP PRICE TARGET TO 2288 (2314) PENCE - 'OVERWEIGHT'

----------

CITIGROUP REINITIATES GLAXOSMITHKLINE WITH 'NEUTRAL' - PRICE TARGET 1840 PENCE

----------

UBS CUTS WM MORRISON SUPERMARKETS PRICE TARGET TO 245 (260) PENCE - 'BUY'

----------

UBS CUTS MICRO FOCUS PRICE TARGET TO 1530 (2050) PENCE - 'BUY'

----------

FTSE 250

----------

BOFA CUTS ASHMORE GROUP TO 'NEUTRAL' ('BUY')

----------

UBS CUTS PAGEGROUP PRICE TARGET TO 440 (495) PENCE - 'NEUTRAL'

----------

UBS CUTS HAYS PRICE TARGET TO 140 (165) PENCE - 'NEUTRAL'

----------

DEUTSCHE BANK RESUMES BELLWAY WITH 'BUY' - TARGET 3538 PENCE

----------

DEUTSCHE BANK RESUMES BOVIS HOMES WITH 'HOLD' - TARGET 1085 PENCE

----------

DEUTSCHE BANK RESUMES MCCARTHY & STONE WITH 'HOLD' - TARGET 137 PENCE

----------

DEUTSCHE BANK RESUMES COUNTRYSIDE PROPERTIES WITH 'BUY' - TARGET 353 PENCE

----------

DEUTSCHE BANK RESUMES REDROW WITH 'BUY' - TARGET 728 PENCE

----------

KEPLER CHEUVREUX CUTS EASYJET TO 'REDUCE' (HOLD) - PRICE TARGET 820 (1200) PENCE

----------

BARCLAYS CUTS LANCASHIRE HOLDINGS PRICE TARGET TO 727 (731) PENCE - 'EQUAL WEIGHT'

----------

BARCLAYS RAISES HASTINGS GROUP PRICE TARGET TO 225 (220) PENCE - 'OVERWEIGHT'

----------

GOLDMAN SACHS RAISES GVC HOLDING PRICE TARGET TO 1000 (950) PENCE - 'BUY'

----------

OTHER MAIN MARKET AND AIM

----------

LIBERUM RAISES AB DYNAMICS PRICE TARGET TO 3085 (2750) PENCE - 'BUY'

----------

More News
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 12:10

LONDON MARKET MIDDAY: Stocks down before Fed minutes and US PMI data

(Alliance News) - Stock prices in London were down at midday on Wednesday, in cautious trade ahead of key US data and central bank minutes in the afternoon.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
29 Dec 2023 13:01

LONDON MARKET CLOSE: UK equities outclassed by other markets in 2023

(Alliance News) - Stock prices in London closed mixed on Friday, the final trading day of 2023, as the annual returns from UK equities were outshone by international markets.

Read more
20 Dec 2023 13:29

GSK buys rights to Hansoh Pharma antibody-drug conjugate

(Sharecast News) - GSK has agreed to buy the rights to an antibody-drug conjugate (ADC) - HS-20093 - from Chinese biopharmaceutical group Hansoh Pharma.

Read more
19 Dec 2023 15:36

German court quashes CureVac patent after challenge by BioNTech

CureVac shares drop 40%Dispute over intellectual property with BioNTech to continue

*

Read more
18 Dec 2023 17:21

Energy stocks lift UK's FTSE 100, Vodafone shines

Vodafone jumps as Iliad offers to merge Italian units

*

Read more
18 Dec 2023 10:07

GSK's dostarlimab trial in endometrial cancer meets primary endpoint

(Alliance News) - GSK PLC on Monday said a trial of dostarlimab in combination with niraparib for treating endometrial cancer has met its primary endpoint.

Read more
18 Dec 2023 07:55

LONDON BRIEFING: Games Workshop seals Amazon deal for Warhammer 40,000

(Alliance News) - Stocks in London were set to retreat slightly on Monday, in line with equity markets in Asia, at the start of the last week before the Christmas holidays.

Read more
18 Dec 2023 07:18

GSK sees success in Jemperli endometrial cancer trial

(Sharecast News) - GSK released positive headline results from the planned analysis of its trial of Jemperli in endometrial cancer on Monday.

Read more
17 Dec 2023 15:16

PRESS: GSK looks for deals in China as rebuilds relationship

(Alliance News) - The Financial Times on Sunday reported that GSK PLC is looking for some new deals in China.

Read more
15 Dec 2023 17:08

European shares end fifth week higher on rate-cut optimism

Barclays sees first ECB rate cut in April

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.